Literature DB >> 31402990

Passive Ceiling Light Disinfection System to Reduce Bioburden in an Intensive Care Unit.

Annie Rohan1, Imraan Khan1, Donglei Yin2, Jie Yang3.   

Abstract

A ceiling-installed narrow spectrum (402-420 nm) bactericidal blue light disinfection system was installed in a large suburban medical intensive care unit (ICU) and evaluated for implementation feasibility and effectiveness in reducing environmental bioburden. Installation of 54 ceiling devices was accomplished at low cost and with minimal ICU process disruption. Postinstallation high-touch surface colony counts were significantly lower than preinstallation. Linear mixed modeling demonstrated a 21% average overall decrease in colony count after installation, with consistent reduction in colony counts starting from week 4 postinstallation. Automated technology is potentially more efficient in reducing environmental bioburden in the acute care setting compared with other bioburden reducing methods or can provide a robust compliment to manual cleaning.

Keywords:  bioburden; blue light technology; infection control; infection prevention; light therapy

Year:  2018        PMID： 31402990      PMCID： PMC6687449          DOI： 10.1055/s-0038-1676655

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN： 2146-4626


  10 in total

1.  G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.

Authors:  Franz Faul; Edgar Erdfelder; Albert-Georg Lang; Axel Buchner
Journal:  Behav Res Methods       Date:  2007-05

2.  Self-sanitizing copper-impregnated surfaces for bioburden reduction in patient rooms.

Authors:  John D Coppin; Frank C Villamaria; Marjory D Williams; Laurel A Copeland; John E Zeber; Chetan Jinadatha
Journal:  Am J Infect Control       Date:  2017-02-22       Impact factor: 2.918

Review 3.  Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.

Authors:  Stephanie J Dancer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Colonization of patients and contamination of the patients' environment by MRSA under conditions of single-room isolation.

Authors:  Ute Rohr; Andrzej Kaminski; Michael Wilhelm; Lars Jurzik; Sören Gatermann; Gert Muhr
Journal:  Int J Hyg Environ Health       Date:  2008-07-29       Impact factor: 5.840

5.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

6.  An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms.

Authors:  Catherine L Passaretti; Jonathan A Otter; Nicholas G Reich; Jessica Myers; John Shepard; Tracy Ross; Karen C Carroll; Pam Lipsett; Trish M Perl
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

Review 7.  Review article: the treatment of refractory Helicobacter pylori infection.

Authors:  F Mégraud; H Lamouliatte
Journal:  Aliment Pharmacol Ther       Date:  2003-06-01       Impact factor: 8.171

Review 8.  Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond.

Authors:  Rui Yin; Tianhong Dai; Pinar Avci; Ana Elisa Serafim Jorge; Wanessa C M A de Melo; Daniela Vecchio; Ying-Ying Huang; Asheesh Gupta; Michael R Hamblin
Journal:  Curr Opin Pharmacol       Date:  2013-09-20       Impact factor: 5.547

Review 9.  Bacterial contamination of inanimate surfaces and equipment in the intensive care unit.

Authors:  Vincenzo Russotto; Andrea Cortegiani; Santi Maurizio Raineri; Antonino Giarratano
Journal:  J Intensive Care       Date:  2015-12-10

Review 10.  Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials.

Authors:  David J Weber; William A Rutala; Deverick J Anderson; Luke F Chen; Emily E Sickbert-Bennett; John M Boyce
Journal:  Am J Infect Control       Date:  2016-05-02       Impact factor: 2.918
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.